NCT01728285View on ClinicalTrials.gov

Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis

PHASE3CompletedINTERVENTIONAL
Enrollment

261

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

October 31, 2009

Conditions
Allergic RhinitisGrass Allergy
Interventions
DEVICE

Electronic compliance device (Memozax®)

An electronic compliance device is distributed to patients allocated to the active arm

Trial Locations (1)

27100

Fondazione IRCCS Policlinico San Matteo, Pavia

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT01728285 - Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis | Biotech Hunter | Biotech Hunter